Skip to main content
. 2021 Sep 27;62(1):117–124. doi: 10.47162/RJME.62.1.11

Figure 10.

Figure 10

Poorly differentiated colon adenocarcinoma with a weak reaction to CD44 within tumor cells. Immunolabeling with anti-CD44 antibody, ×200. CD44: Cluster of differentiation 44